NeoGenomics (NASDAQ:NEO) Stock Rating Lowered by Raymond James

Raymond James cut shares of NeoGenomics (NASDAQ:NEO – Get Rating) from an outperform rating to a market perform rating in a research report report published on Tuesday morning, The Fly reports. A number of other research analysts have also weighed in on NEO. Cowen boosted their target price on NeoGenomics from $14.00 to $20.00 and […]

Related Keywords

Raymond James ,Commonwealth Of Pennsylvania Public School Empls Retrmt ,Clinical Services ,Metlife Investment Management ,Alphacrest Capital Management ,Neogenomics Inc ,Needham Company ,Citigroup Inc ,Pharma Services ,Get Rating ,Moderate Buy ,Genomics Trading Down ,Crest Capital Management ,Life Investment Management ,Pennsylvania Public School Empls Retrmt ,Neogenomics Daily ,Neogenomics ,Nasdaq Neo ,Neo ,Medical ,Downgrade ,